JO
IMCR icon

John Overdeck’s Immunocore IMCR Stock Holding History

John Overdeck’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.4M Buy
1,648,983
+627,718
+61% +$18.6M 0.04% 538
2026
Q1 		$30.8M Buy
1,021,265
+661,972
+184% +$21.4M 0.02% 713
2025
Q4 		$12.5M Buy
359,293
+138,597
+63% +$4.89M 0.02% 983
2025
Q3 		$8.02M Sell
220,696
-212,369
-49% -$7.22M 0.01% 1083
2025
Q2 		$13.6M Buy
433,065
+127,701
+42% +$3.97M 0.02% 687
2025
Q1 		$9.06M Sell
305,364
-85,436
-22% -$2.56M 0.02% 804
2024
Q4 		$11.5M Sell
390,800
-206,342
-35% -$6.52M 0.03% 686
2024
Q3 		$18.6M Buy
597,142
+157,689
+36% +$5.74M 0.04% 518
2024
Q2 		$14.9M Buy
439,453
+303,804
+224% +$15.5M 0.03% 562
2024
Q1 		$8.82M Sell
135,649
-26,308
-16% -$1.81M 0.02% 701
2023
Q4 		$11.1M Buy
161,957
+9,864
+6% +$513K 0.03% 633
2023
Q3 		$7.89M Sell
152,093
-49,038
-24% -$2.9M 0.02% 691
2023
Q2 		$12.1M Buy
201,131
+100,486
+100% +$5.74M 0.03% 567
2023
Q1 		$4.98M Buy
100,645
+29,264
+41% +$1.65M 0.01% 914
2022
Q4 		$4.07M Buy
+71,381
New +$4.02M 0.01% 950

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

John Overdeck's IMCR Position: Q2 2026 in Review

John Overdeck increased its Immunocore (IMCR) stake by 61% in Q2 2026, buying an estimated $18.6M and bringing the position to 1,648,983 shares worth $52.4M. The position accounts for 0.04% of the portfolio, ranked #538.

John Overdeck first reported a position in IMCR in Q4 2022 and has held it in 15 quarters since. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • John Overdeck held 1,648,983 shares of Immunocore worth $52.4M as of Q2 2026.
  • John Overdeck bought 627,718 Immunocore shares in Q2 2026, an estimated $18.6M.
  • Immunocore made up 0.04% of John Overdeck's portfolio in Q2 2026, its #538 holding.
  • John Overdeck first reported a position in Immunocore in Q4 2022 and has held it in 15 quarters since.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.